BCL2 and Miyoshi myopathy: Given that Bcl-2 has been directly implicated in survival and resistance of AML and MM cells from several therapies30,31, we performed cytotoxicity assays in the presence of stroma with or without the addition of a Bcl-2 inhibitor HA14-1.